Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Lexaria Bioscience Corp. (LEXX)

CollPlant Biotechnologies Ltd. Sponsored ADR and Lexaria Bioscience Corp. are both Biotechnology companies. Lexaria Bioscience Corp. is the larger, with a market value of $8.8M against $7.5M — 1.2× the size. Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 9.08% against −86.8%. Lexaria Bioscience Corp. has the higher net margin (0.00% vs −3,934.9%) and the lower return on invested capital (−662.6% vs 0.00%). Across the 17 metrics below, Lexaria Bioscience Corp. leads on 13 and CollPlant Biotechnologies Ltd. Sponsored ADR on 4.

Valuation

Metric CLGN LEXX Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 12.64 9.18
P/B 1.97 1.58 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 26.12 6.08 8.98
Earnings yield (235.64%) (126.07%) (34.89%)
Free cash flow yield (193.83%) (109.89%) (24.52%)

Profitability

Metric CLGN LEXX Biotechnology median
Gross margin (321.70%) 100.00% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (162.60%) (50.12%)
Return on assets (101.59%) (134.20%) (45.60%)
Return on invested capital 0.00% (662.56%) 0.00%

Growth

Metric CLGN LEXX Biotechnology median
Revenue growth (TTM) (86.76%) 9.08% 6.26%
EPS growth (last fiscal year) 35.17% (40.43%) 29.88%
Revenue growth, 5-year CAGR (17.32%) 17.53% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN LEXX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 10.60 4.89
Net debt to EBITDA 0.56 0.17 1.01

Dividend

Metric CLGN LEXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN LEXX Biotechnology median
Market cap 7.45m 8.78m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack